NO20005385L - Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasöytisk anvendelige salter eller hydrater - Google Patents

Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasöytisk anvendelige salter eller hydrater

Info

Publication number
NO20005385L
NO20005385L NO20005385A NO20005385A NO20005385L NO 20005385 L NO20005385 L NO 20005385L NO 20005385 A NO20005385 A NO 20005385A NO 20005385 A NO20005385 A NO 20005385A NO 20005385 L NO20005385 L NO 20005385L
Authority
NO
Norway
Prior art keywords
gatifloxacin
hydrates
pharmaceutically acceptable
acceptable salts
medicinal products
Prior art date
Application number
NO20005385A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005385D0 (no
Inventor
Johannes Heinich Bartholomaeus
Juergen Betzing
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20005385L publication Critical patent/NO20005385L/no
Publication of NO20005385D0 publication Critical patent/NO20005385D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005385A 1998-05-09 2000-10-26 Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasøytisk anvendelige salter eller hydrater NO20005385D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19820801A DE19820801A1 (de) 1998-05-09 1998-05-09 Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
PCT/EP1999/002893 WO1999058129A1 (de) 1998-05-09 1999-04-29 Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten

Publications (2)

Publication Number Publication Date
NO20005385L true NO20005385L (no) 2000-10-26
NO20005385D0 NO20005385D0 (no) 2000-10-26

Family

ID=7867223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005385A NO20005385D0 (no) 1998-05-09 2000-10-26 Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasøytisk anvendelige salter eller hydrater

Country Status (28)

Country Link
US (1) US6291462B1 (es)
EP (1) EP1077703B1 (es)
JP (1) JP2002514600A (es)
KR (1) KR100587210B1 (es)
CN (1) CN1198615C (es)
AR (1) AR019279A1 (es)
AT (1) ATE235242T1 (es)
AU (1) AU753482B2 (es)
BR (1) BR9910350A (es)
CA (1) CA2325636A1 (es)
CO (1) CO5050341A1 (es)
DE (2) DE19820801A1 (es)
DK (1) DK1077703T3 (es)
ES (1) ES2195573T3 (es)
HK (1) HK1033281A1 (es)
HU (1) HUP0101597A3 (es)
IL (1) IL139512A0 (es)
MY (1) MY118569A (es)
NO (1) NO20005385D0 (es)
NZ (1) NZ507968A (es)
PE (1) PE20000480A1 (es)
PL (1) PL343936A1 (es)
PT (1) PT1077703E (es)
RU (1) RU2226394C2 (es)
SK (1) SK16772000A3 (es)
UA (1) UA60364C2 (es)
WO (1) WO1999058129A1 (es)
ZA (1) ZA200006440B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
US6413969B1 (en) * 2000-09-13 2002-07-02 Bristol-Myers Squibb Company Gatifloxacin pentahydrate
DE60230934D1 (de) * 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
US6589955B2 (en) * 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
US20050031683A1 (en) * 2003-08-04 2005-02-10 Ashish Kapoor Solid pharmaceutical composition
WO2005021000A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
PE20110121A1 (es) * 2004-03-17 2011-02-28 Novartis Ag Composiciones farmaceuticas de aliskiren
PT1828167E (pt) * 2004-06-04 2014-10-08 Debiopharm Int Sa Derivados de acrilamida como agentes antibióticos
US20060247255A1 (en) * 2005-05-02 2006-11-02 Patel Satishkumar A Method for preparing a stable gatifloxacin composition
PT1909736E (pt) * 2005-08-02 2014-12-23 Baxter Int Indicador de oxigénio para utilização em produtos médicos e pacote contendo um indicador de oxigénio
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
CN100415212C (zh) * 2006-07-21 2008-09-03 哈药集团制药总厂 一种含乳酸卡德沙星的口服制剂
CA2563690C (en) * 2006-10-12 2014-10-07 Pharmascience Inc. Pharmaceutical compositions comprising intra- and extra- granular fractions
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
LT2861608T (lt) 2012-06-19 2019-07-10 Debiopharm International Sa (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-nafthidrin-3-il)akrilamido provaisto dariniai
HUE052140T2 (hu) 2016-02-26 2021-04-28 Debiopharm Int Sa Diabéteszes lábfertõzések kezelésére szolgáló gyógyszer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH089597B2 (ja) 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5436253A (en) * 1993-09-08 1995-07-25 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives and mycotic infections
US5858411A (en) * 1994-12-19 1999-01-12 Daiichi Pharmaceutical Co., Ltd. Sustained-release granular preparations and production process thereof
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
DE19820801A1 (de) 1999-11-25
JP2002514600A (ja) 2002-05-21
EP1077703A1 (de) 2001-02-28
CN1198615C (zh) 2005-04-27
NZ507968A (en) 2002-12-20
EP1077703B1 (de) 2003-03-26
RU2226394C2 (ru) 2004-04-10
SK16772000A3 (sk) 2001-05-10
PL343936A1 (en) 2001-09-10
HUP0101597A3 (en) 2003-01-28
BR9910350A (pt) 2001-09-25
MY118569A (en) 2004-12-31
KR20010043408A (ko) 2001-05-25
ATE235242T1 (de) 2003-04-15
DE59904737D1 (de) 2003-04-30
AU4035299A (en) 1999-11-29
CN1300216A (zh) 2001-06-20
CA2325636A1 (en) 1999-11-18
DK1077703T3 (da) 2003-06-23
PT1077703E (pt) 2003-08-29
UA60364C2 (uk) 2003-10-15
PE20000480A1 (es) 2000-05-20
NO20005385D0 (no) 2000-10-26
WO1999058129A1 (de) 1999-11-18
US6291462B1 (en) 2001-09-18
IL139512A0 (en) 2001-11-25
KR100587210B1 (ko) 2006-06-08
HUP0101597A2 (hu) 2001-11-28
ZA200006440B (en) 2002-02-08
AU753482B2 (en) 2002-10-17
CO5050341A1 (es) 2001-06-27
AR019279A1 (es) 2002-02-13
ES2195573T3 (es) 2003-12-01
HK1033281A1 (en) 2001-08-24

Similar Documents

Publication Publication Date Title
NO20005385D0 (no) Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasøytisk anvendelige salter eller hydrater
IL160977A0 (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
AU2002346973A1 (en) Oral Dosage Form for Propiverine or its Pharmaceutically Acceptable Salts with an Extended Release of the Active Ingredient
DK1207867T3 (da) Retarderede, orale farmaceutiske indgivelsesformer med tramadol
NO992097D0 (no) Polymerholdig preparat med kontrollert avgivelse av aktiv forbindelse
EE200100495A (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
LTPA2014005I1 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
NO20002977L (no) Terapeutisk formulering for administrasjon av tolterodin med kontrollert frigivelse
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
NO20012248L (no) Farmasöytisk preparat av moksifloksacin
EE200000659A (et) 4-(3,5-bis-trifluorometüülbensüülamino)-2-etüül-6-trifluorometüül-3,4-dihüdro-2H-kin oliin-1-karboksüülhappe etüülestrid või nende soolad ja valmistamise meetodid
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO991613L (no) Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering
EG24397A (en) Salts of keto acids and amine derivatives and their use for the preparation of medicaments
NO20021368D0 (no) Fremgangsmåte for fremstilling av fenyleddiksyre-derivater
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20013851D0 (no) Salter med opprettholdt frigivning av farmasoytisk ative peptider samt fremstilling derav
AU5241200A (en) Retard formulation of amoxicillin for oral administration
DK1071397T3 (da) Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
SI1077703T1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
EE04612B1 (et) 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat
NO20013453L (no) Fremgangsmate for fremstilling av salter av cyanobenzylaminer
HUP9904011A3 (en) Novel salts of dipeptid derivatives and use of them for producing pharmaceutical compositions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application